These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38893194)

  • 1. Overlapping Stromal Alterations in Myeloid and Lymphoid Neoplasms.
    Bogun L; Koch A; Scherer B; Germing U; Fenk R; Maus U; Bormann F; Köhrer K; Petzsch P; Wachtmeister T; Kobbe G; Dietrich S; Haas R; Schroeder T; Geyh S; Jäger P
    Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis.
    Wenk C; Garz AK; Grath S; Huberle C; Witham D; Weickert M; Malinverni R; Niggemeyer J; Kyncl M; Hecker J; Pagel C; Mulholland CB; Müller-Thomas C; Leonhardt H; Bassermann F; Oostendorp RAJ; Metzeler KH; Buschbeck M; Götze KS
    Blood Adv; 2018 Dec; 2(23):3447-3461. PubMed ID: 30518537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
    Pleyer L; Valent P; Greil R
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27355944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow niche in the myelodysplastic syndromes.
    Cogle CR; Saki N; Khodadi E; Li J; Shahjahani M; Azizidoost S
    Leuk Res; 2015 Oct; 39(10):1020-7. PubMed ID: 26276090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Changes in Immunological Characteristics of Bone Marrow Multipotent Mesenchymal Stromal Cells in Lymphoid Neoplasia.
    Petinati NA; Sadovskaya AV; Sats NV; Kapranov NM; Davydova YO; Fastova EA; Magomedova AU; Vasilyeva AN; Aleshina OA; Arapidi GP; Shender VO; Smirnov IP; Pobeguts OV; Lagarkova MA; Drize NI; Parovichnikova EN
    Biochemistry (Mosc); 2024 May; 89(5):883-903. PubMed ID: 38880649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.
    Kastrinaki MC; Pontikoglou C; Klaus M; Stavroulaki E; Pavlaki K; Papadaki HA
    Curr Stem Cell Res Ther; 2011 Jun; 6(2):122-30. PubMed ID: 20528751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes.
    Mattiucci D; Maurizi G; Leoni P; Poloni A
    Cell Transplant; 2018 May; 27(5):754-764. PubMed ID: 29682980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow-derived mesenchymal stem/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality.
    Zhang L; Chi Y; Wei Y; Zhang W; Wang F; Zhang L; Zou L; Song B; Zhao X; Han Z
    Stem Cell Res Ther; 2021 Jun; 12(1):365. PubMed ID: 34174939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Azuma K; Umezu T; Imanishi S; Asano M; Yoshizawa S; Katagiri S; Ohyashiki K; Ohyashiki JH
    Leuk Res; 2017 Nov; 62():23-28. PubMed ID: 28964959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
    Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
    J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mesenchymal stromal cell-derived extracellular matrix displays altered glycosaminoglycan structure and impaired functionality in Myelodysplastic Syndromes.
    Bains AK; Behrens Wu L; Rivière J; Rother S; Magno V; Friedrichs J; Werner C; Bornhäuser M; Götze KS; Cross M; Platzbecker U; Wobus M
    Front Oncol; 2022; 12():961473. PubMed ID: 36158640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome.
    Zheng L; Zhang L; Guo Y; Xu X; Liu Z; Yan Z; Fu R
    Front Immunol; 2022; 13():1078421. PubMed ID: 36569863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells.
    Sorokina T; Shipounova I; Bigildeev A; Petinati N; Drize N; Turkina A; Chelysheva E; Shukhov O; Kuzmina L; Parovichnikova E; Savchenko V
    Eur J Haematol; 2016 Sep; 97(3):245-52. PubMed ID: 26643284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.